BIOXCEL THERAPEUTICS INC

CUSIP: 09075P105 Class: Common Stock

TOCQUEVILLE ASSET MANAGEMENT L.P.'s Holding History (CIK: 0000883961)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 11,800 Value ($000) $4 Avg Close — Range —
Q3 2024
Shares 11,900 Value ($000) $7 Avg Close — Range —
Q2 2024
Shares 43,750 Value ($000) $56 Avg Close — Range —
Q1 2024
Shares 48,250 Value ($000) $136 Avg Close — Range —
Q4 2023
Shares 50,250 Value ($000) $148 Avg Close — Range —
Q3 2023
Shares 39,600 Value ($000) $100 Avg Close — Range —
Q2 2023
Shares 39,600 Value ($000) $264 Avg Close — Range —
Q1 2023
Shares 37,000 Value ($000) $690 Avg Close — Range —
Q4 2022
Shares 39,400 Value ($000) $846 Avg Close — Range —
Q3 2022
Shares 28,650 Value ($000) $339 Avg Close — Range —
Q2 2022
Shares 31,450 Value ($000) $415 Avg Close — Range —
Q1 2022
Shares 18,700 Value ($000) $391 Avg Close — Range —
Q4 2021
Shares 17,400 Value ($000) $354 Avg Close — Range —
Q3 2021
Shares 18,200 Value ($000) $552 Avg Close — Range —
Q2 2021
Shares 19,700 Value ($000) $572 Avg Close — Range —
Q1 2021
Shares 14,550 Value ($000) $628 Avg Close — Range —
Q4 2020
Shares 5,100 Value ($000) $236 Avg Close — Range —
Q3 2020
Shares 4,700 Value ($000) $204 Avg Close — Range —